van Lierop, Zoë Y. G. J
18  Ergebnisse:
Personensuche X
?
2

Pre-analytical stability of serum biomarkers for neurologic..:

van Lierop, Zoë Y. G. J. ; Verberk, Inge M. W. ; van Uffelen, Kees W. J....
Clinical Chemistry and Laboratory Medicine (CCLM).  60 (2022)  6 - p. 842-850 , 2022
 
?
 
?
7

Serum Neurofilament Light Association With Progression in N..:

Bridel, Claire ; Leurs, Cyra E ; van Lierop, Zoë Y G J...
info:eu-repo/semantics/altIdentifier/doi/10.1212/WNL.0000000000012752.  , 2021
 
?
8

Project Y:The search for clues explaining phenotype variabi..:

Loonstra, Floor C ; De Ruiter, Lodewijk R.J ; Doesburg, Djoeke...
Loonstra , F C , De Ruiter , L R J , Doesburg , D , Lam , K H , Van Lierop , Z Y G J , Moraal , B , Strijbis , E M M , Killestein , J & Uitdehaag , B M J 2021 , ' Project Y : The search for clues explaining phenotype variability in MS ' , Multiple Sclerosis and Related Disorders . https://doi.org/10.1016/j.msard.2021.103337.  , 2021
 
?
10

Thyroid Gland F-18-FDG Uptake in Neurofibromatosis Type 1:

van Lierop, Zoe Y. G. J ; Jentjens, Sander ; Anten, Monique H. M. E...
van Lierop , Z Y G J , Jentjens , S , Anten , M H M E , Wierts , R , Stumpel , C T , Havekes , B & van Kroonenburgh , M J P G 2018 , ' Thyroid Gland F-18-FDG Uptake in Neurofibromatosis Type 1 ' , European Thyroid Journal , vol. 7 , no. 3 , pp. 155-161 . https://doi.org/10.1159/000488706.  , 2018
 
?
12

Personalized B-cell tailored dosing of ocrelizumab in patie..:

van Lierop, Zoë Y. GJ ; Toorop, Alyssa A ; van Ballegoij, Wouter J. C...
van Lierop , Z Y GJ , Toorop , A A , van Ballegoij , W J C , Olde Dubbelink , T B G , Strijbis , E M M , de Jong , B A , van Oosten , B W , Moraal , B , Teunissen , C E , Uitdehaag , B M J , Killestein , J & Kempen , Z L E V 2021 , ' Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic ' , Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211028833.  , 2021
 
?
13

The wearing-off phenomenon of ocrelizumab in patients with ..:

Toorop, A.A. ; van Lierop, Z.Y.G.J. ; Strijbis, E.M.M....
Multiple Sclerosis and Related Disorders.  57 (2022)  - p. 103364 , 2022
 
?
14

Natalizumab discontinuation in a Dutch real-world cohort:

Coerver, E.M.E. ; Wessels, M.H.J. ; van Lierop, Z.Y.G....
Multiple Sclerosis and Related Disorders.  52 (2021)  - p. 102974 , 2021
 
?
 
1-15